A part of Takeda Pharmaceutical Company Ltd headquartered in Japan, Takeda India specialises in gastrointestinal and inflammation, rare diseases, plasma-derived therapies, oncology etc.
New-age digital entertainment and technology company, JetSynthesys, is pleased to announce the appointment of Raj Thadani as the CEO of its Joint Venture (JV) with Digital Hearts Holdings (DHH), a Japanese holding company listed on the Tokyo Stock Exchange (TSE). In his new capacity, Thadani will spearhead strategic initiatives, drawing on DHH’s expertise to bolster India’s gaming supply […]